M Ventures and Debiopharm led a €15m Series A funding in Iktos.

M Ventures, a strategic corporate venture capital fund, and Debiopharm, an independent biopharmaceutical company, led a €15m Series A funding in Iktos, a deep learning technology platform, with participation from Omnes Capital, a private equity firm. “The technologies we have developed have been enabling multiple partners in realizing this promise. We welcome our new, experienced, investor syndicate and fresh financing that will allow us to execute our plan of being the preferred partner for the industry to address their drug development needs,” Yann Gaston-Mathé, Iktos President and Co-Founder.